nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—ALB—type 1 diabetes mellitus	0.41	1	CbGaD
Celecoxib—Ischaemic stroke—Ramipril—type 1 diabetes mellitus	0.0205	0.11	CcSEcCtD
Celecoxib—CA6—saliva—type 1 diabetes mellitus	0.0156	0.171	CbGeAlD
Celecoxib—ORM1—saliva—type 1 diabetes mellitus	0.0083	0.0909	CbGeAlD
Celecoxib—Blood potassium increased—Ramipril—type 1 diabetes mellitus	0.00781	0.0422	CcSEcCtD
Celecoxib—PDPK1—retina—type 1 diabetes mellitus	0.00614	0.0673	CbGeAlD
Celecoxib—PDPK1—nephron tubule—type 1 diabetes mellitus	0.00578	0.0634	CbGeAlD
Celecoxib—Cerebrovascular disorder—Ramipril—type 1 diabetes mellitus	0.00528	0.0285	CcSEcCtD
Celecoxib—PDPK1—kidney—type 1 diabetes mellitus	0.00508	0.0557	CbGeAlD
Celecoxib—Transient ischaemic attack—Ramipril—type 1 diabetes mellitus	0.00468	0.0252	CcSEcCtD
Celecoxib—PDPK1—lymphoid tissue—type 1 diabetes mellitus	0.00437	0.0479	CbGeAlD
Celecoxib—Hepatic necrosis—Ramipril—type 1 diabetes mellitus	0.00406	0.0219	CcSEcCtD
Celecoxib—CA9—islet of Langerhans—type 1 diabetes mellitus	0.00394	0.0432	CbGeAlD
Celecoxib—CA4—nerve—type 1 diabetes mellitus	0.00373	0.0408	CbGeAlD
Celecoxib—Neuralgia—Ramipril—type 1 diabetes mellitus	0.0034	0.0183	CcSEcCtD
Celecoxib—Ageusia—Ramipril—type 1 diabetes mellitus	0.00291	0.0157	CcSEcCtD
Celecoxib—MAPK14—cardiovascular system—type 1 diabetes mellitus	0.00278	0.0305	CbGeAlD
Celecoxib—MAPK14—kidney—type 1 diabetes mellitus	0.00272	0.0298	CbGeAlD
Celecoxib—Proteinuria—Ramipril—type 1 diabetes mellitus	0.00269	0.0145	CcSEcCtD
Celecoxib—Protein urine present—Ramipril—type 1 diabetes mellitus	0.00265	0.0143	CcSEcCtD
Celecoxib—Drug interaction—Ramipril—type 1 diabetes mellitus	0.00254	0.0137	CcSEcCtD
Celecoxib—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.00248	0.0134	CcSEcCtD
Celecoxib—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.00248	0.0134	CcSEcCtD
Celecoxib—Vasculitis—Ramipril—type 1 diabetes mellitus	0.00242	0.013	CcSEcCtD
Celecoxib—MAPK14—lymphoid tissue—type 1 diabetes mellitus	0.00234	0.0256	CbGeAlD
Celecoxib—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.00223	0.012	CcSEcCtD
Celecoxib—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00222	0.012	CcSEcCtD
Celecoxib—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00214	0.0116	CcSEcCtD
Celecoxib—CA12—kidney—type 1 diabetes mellitus	0.00206	0.0226	CbGeAlD
Celecoxib—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00198	0.0107	CcSEcCtD
Celecoxib—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00195	0.0105	CcSEcCtD
Celecoxib—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00193	0.0104	CcSEcCtD
Celecoxib—Deafness—Ramipril—type 1 diabetes mellitus	0.00191	0.0103	CcSEcCtD
Celecoxib—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00191	0.0103	CcSEcCtD
Celecoxib—CA5B—cardiovascular system—type 1 diabetes mellitus	0.00189	0.0207	CbGeAlD
Celecoxib—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00186	0.01	CcSEcCtD
Celecoxib—CA5B—pancreas—type 1 diabetes mellitus	0.00184	0.0201	CbGeAlD
Celecoxib—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00182	0.00979	CcSEcCtD
Celecoxib—CA4—islet of Langerhans—type 1 diabetes mellitus	0.0018	0.0198	CbGeAlD
Celecoxib—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.00177	0.00955	CcSEcCtD
Celecoxib—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00175	0.00947	CcSEcCtD
Celecoxib—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.00175	0.00947	CcSEcCtD
Celecoxib—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00175	0.00943	CcSEcCtD
Celecoxib—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00172	0.00928	CcSEcCtD
Celecoxib—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.0016	0.00866	CcSEcCtD
Celecoxib—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00158	0.00853	CcSEcCtD
Celecoxib—ABCC4—nephron tubule—type 1 diabetes mellitus	0.00158	0.0173	CbGeAlD
Celecoxib—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.00156	0.00844	CcSEcCtD
Celecoxib—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00155	0.00835	CcSEcCtD
Celecoxib—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00154	0.00832	CcSEcCtD
Celecoxib—Gastritis—Ramipril—type 1 diabetes mellitus	0.00152	0.00818	CcSEcCtD
Celecoxib—CA2—islet of Langerhans—type 1 diabetes mellitus	0.0015	0.0164	CbGeAlD
Celecoxib—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00148	0.00799	CcSEcCtD
Celecoxib—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00147	0.00791	CcSEcCtD
Celecoxib—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00146	0.00786	CcSEcCtD
Celecoxib—CA4—nephron tubule—type 1 diabetes mellitus	0.00145	0.0159	CbGeAlD
Celecoxib—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00145	0.00783	CcSEcCtD
Celecoxib—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00144	0.00778	CcSEcCtD
Celecoxib—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00144	0.00778	CcSEcCtD
Celecoxib—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00142	0.00768	CcSEcCtD
Celecoxib—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00141	0.00759	CcSEcCtD
Celecoxib—ABCC4—kidney—type 1 diabetes mellitus	0.00139	0.0152	CbGeAlD
Celecoxib—ABCC4—pancreas—type 1 diabetes mellitus	0.00138	0.0151	CbGeAlD
Celecoxib—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00138	0.00742	CcSEcCtD
Celecoxib—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00135	0.00729	CcSEcCtD
Celecoxib—Weight increased—Ramipril—type 1 diabetes mellitus	0.00135	0.00727	CcSEcCtD
Celecoxib—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00131	0.00706	CcSEcCtD
Celecoxib—CA4—cardiovascular system—type 1 diabetes mellitus	0.00131	0.0143	CbGeAlD
Celecoxib—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.0013	0.00702	CcSEcCtD
Celecoxib—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00129	0.00698	CcSEcCtD
Celecoxib—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00129	0.00698	CcSEcCtD
Celecoxib—Jaundice—Ramipril—type 1 diabetes mellitus	0.00129	0.00694	CcSEcCtD
Celecoxib—Stomatitis—Ramipril—type 1 diabetes mellitus	0.00129	0.00694	CcSEcCtD
Celecoxib—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00128	0.00692	CcSEcCtD
Celecoxib—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00128	0.00692	CcSEcCtD
Celecoxib—CA2—retina—type 1 diabetes mellitus	0.00128	0.014	CbGeAlD
Celecoxib—CA4—kidney—type 1 diabetes mellitus	0.00128	0.014	CbGeAlD
Celecoxib—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00125	0.00674	CcSEcCtD
Celecoxib—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00124	0.00672	CcSEcCtD
Celecoxib—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00124	0.00668	CcSEcCtD
Celecoxib—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00123	0.00665	CcSEcCtD
Celecoxib—CA2—nephron tubule—type 1 diabetes mellitus	0.00121	0.0132	CbGeAlD
Celecoxib—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00118	0.00639	CcSEcCtD
Celecoxib—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00117	0.0063	CcSEcCtD
Celecoxib—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00116	0.00628	CcSEcCtD
Celecoxib—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00112	0.00605	CcSEcCtD
Celecoxib—PTGS2—islet of Langerhans—type 1 diabetes mellitus	0.0011	0.0121	CbGeAlD
Celecoxib—Tinnitus—Ramipril—type 1 diabetes mellitus	0.0011	0.00596	CcSEcCtD
Celecoxib—Flushing—Ramipril—type 1 diabetes mellitus	0.0011	0.00593	CcSEcCtD
Celecoxib—CA2—cardiovascular system—type 1 diabetes mellitus	0.00108	0.0119	CbGeAlD
Celecoxib—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00107	0.00577	CcSEcCtD
Celecoxib—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00107	0.00576	CcSEcCtD
Celecoxib—CA2—kidney—type 1 diabetes mellitus	0.00106	0.0116	CbGeAlD
Celecoxib—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00106	0.00571	CcSEcCtD
Celecoxib—CA2—pancreas—type 1 diabetes mellitus	0.00105	0.0115	CbGeAlD
Celecoxib—Alopecia—Ramipril—type 1 diabetes mellitus	0.00105	0.00565	CcSEcCtD
Celecoxib—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00104	0.0056	CcSEcCtD
Celecoxib—Tension—Ramipril—type 1 diabetes mellitus	0.00101	0.00546	CcSEcCtD
Celecoxib—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00101	0.00545	CcSEcCtD
Celecoxib—Nervousness—Ramipril—type 1 diabetes mellitus	0.001	0.00541	CcSEcCtD
Celecoxib—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000992	0.00535	CcSEcCtD
Celecoxib—Angioedema—Ramipril—type 1 diabetes mellitus	0.000942	0.00509	CcSEcCtD
Celecoxib—Vertigo—Ramipril—type 1 diabetes mellitus	0.000927	0.005	CcSEcCtD
Celecoxib—Syncope—Ramipril—type 1 diabetes mellitus	0.000925	0.00499	CcSEcCtD
Celecoxib—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000923	0.00498	CcSEcCtD
Celecoxib—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.000916	0.01	CbGeAlD
Celecoxib—Palpitations—Ramipril—type 1 diabetes mellitus	0.000911	0.00492	CcSEcCtD
Celecoxib—CA2—lymphoid tissue—type 1 diabetes mellitus	0.00091	0.00997	CbGeAlD
Celecoxib—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000907	0.00489	CcSEcCtD
Celecoxib—Cough—Ramipril—type 1 diabetes mellitus	0.0009	0.00486	CcSEcCtD
Celecoxib—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000878	0.00474	CcSEcCtD
Celecoxib—Chest pain—Ramipril—type 1 diabetes mellitus	0.000878	0.00474	CcSEcCtD
Celecoxib—Myalgia—Ramipril—type 1 diabetes mellitus	0.000878	0.00474	CcSEcCtD
Celecoxib—Anxiety—Ramipril—type 1 diabetes mellitus	0.000875	0.00472	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000872	0.00471	CcSEcCtD
Celecoxib—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000859	0.00463	CcSEcCtD
Celecoxib—Confusional state—Ramipril—type 1 diabetes mellitus	0.000849	0.00458	CcSEcCtD
Celecoxib—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000842	0.00454	CcSEcCtD
Celecoxib—Oedema—Ramipril—type 1 diabetes mellitus	0.000842	0.00454	CcSEcCtD
Celecoxib—Shock—Ramipril—type 1 diabetes mellitus	0.000828	0.00447	CcSEcCtD
Celecoxib—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000826	0.00445	CcSEcCtD
Celecoxib—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000824	0.00445	CcSEcCtD
Celecoxib—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000822	0.00443	CcSEcCtD
Celecoxib—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000818	0.00441	CcSEcCtD
Celecoxib—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000814	0.00439	CcSEcCtD
Celecoxib—Anorexia—Ramipril—type 1 diabetes mellitus	0.000802	0.00433	CcSEcCtD
Celecoxib—PTGS2—cardiovascular system—type 1 diabetes mellitus	0.000799	0.00876	CbGeAlD
Celecoxib—PTGS2—kidney—type 1 diabetes mellitus	0.000782	0.00857	CbGeAlD
Celecoxib—PTGS2—pancreas—type 1 diabetes mellitus	0.000777	0.00851	CbGeAlD
Celecoxib—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000767	0.00414	CcSEcCtD
Celecoxib—Insomnia—Ramipril—type 1 diabetes mellitus	0.000761	0.00411	CcSEcCtD
Celecoxib—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000756	0.00408	CcSEcCtD
Celecoxib—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00075	0.00405	CcSEcCtD
Celecoxib—Somnolence—Ramipril—type 1 diabetes mellitus	0.000748	0.00404	CcSEcCtD
Celecoxib—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000741	0.004	CcSEcCtD
Celecoxib—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000732	0.00395	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000727	0.00392	CcSEcCtD
Celecoxib—Fatigue—Ramipril—type 1 diabetes mellitus	0.000726	0.00392	CcSEcCtD
Celecoxib—Constipation—Ramipril—type 1 diabetes mellitus	0.00072	0.00388	CcSEcCtD
Celecoxib—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000694	0.00374	CcSEcCtD
Celecoxib—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000688	0.00371	CcSEcCtD
Celecoxib—CYP3A4—kidney—type 1 diabetes mellitus	0.000683	0.00749	CbGeAlD
Celecoxib—CYP2D6—kidney—type 1 diabetes mellitus	0.000672	0.00737	CbGeAlD
Celecoxib—PTGS2—lymphoid tissue—type 1 diabetes mellitus	0.000672	0.00736	CbGeAlD
Celecoxib—Urticaria—Ramipril—type 1 diabetes mellitus	0.000669	0.00361	CcSEcCtD
Celecoxib—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000665	0.00359	CcSEcCtD
Celecoxib—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000665	0.00359	CcSEcCtD
Celecoxib—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00062	0.00335	CcSEcCtD
Celecoxib—Asthenia—Ramipril—type 1 diabetes mellitus	0.000604	0.00326	CcSEcCtD
Celecoxib—Pruritus—Ramipril—type 1 diabetes mellitus	0.000596	0.00321	CcSEcCtD
Celecoxib—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000576	0.00311	CcSEcCtD
Celecoxib—Dizziness—Ramipril—type 1 diabetes mellitus	0.000557	0.003	CcSEcCtD
Celecoxib—Vomiting—Ramipril—type 1 diabetes mellitus	0.000535	0.00289	CcSEcCtD
Celecoxib—Rash—Ramipril—type 1 diabetes mellitus	0.000531	0.00286	CcSEcCtD
Celecoxib—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00053	0.00286	CcSEcCtD
Celecoxib—Headache—Ramipril—type 1 diabetes mellitus	0.000527	0.00285	CcSEcCtD
Celecoxib—Nausea—Ramipril—type 1 diabetes mellitus	0.0005	0.0027	CcSEcCtD
Celecoxib—PTGS2—Metabolism—G6PC2—type 1 diabetes mellitus	4.6e-05	0.000147	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VAV1—type 1 diabetes mellitus	4.58e-05	0.000146	CbGpPWpGaD
Celecoxib—CA14—Metabolism—NOS3—type 1 diabetes mellitus	4.58e-05	0.000146	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	4.57e-05	0.000146	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CRP—type 1 diabetes mellitus	4.55e-05	0.000145	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	4.52e-05	0.000144	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD80—type 1 diabetes mellitus	4.51e-05	0.000144	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—NOS3—type 1 diabetes mellitus	4.47e-05	0.000142	CbGpPWpGaD
Celecoxib—CA6—Metabolism—NOS3—type 1 diabetes mellitus	4.47e-05	0.000142	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—STAT3—type 1 diabetes mellitus	4.45e-05	0.000142	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—ALB—type 1 diabetes mellitus	4.42e-05	0.000141	CbGpPWpGaD
Celecoxib—CA12—Metabolism—INS—type 1 diabetes mellitus	4.4e-05	0.00014	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	4.38e-05	0.00014	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—ALB—type 1 diabetes mellitus	4.36e-05	0.000139	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—INS—type 1 diabetes mellitus	4.31e-05	0.000137	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NOS2—type 1 diabetes mellitus	4.29e-05	0.000137	CbGpPWpGaD
Celecoxib—CA9—Metabolism—CAT—type 1 diabetes mellitus	4.28e-05	0.000136	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DPB1—type 1 diabetes mellitus	4.27e-05	0.000136	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—NOS3—type 1 diabetes mellitus	4.23e-05	0.000135	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-E—type 1 diabetes mellitus	4.21e-05	0.000134	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GAL—type 1 diabetes mellitus	4.17e-05	0.000133	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—STAT3—type 1 diabetes mellitus	4.17e-05	0.000133	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—NOS3—type 1 diabetes mellitus	4.17e-05	0.000133	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	4.17e-05	0.000133	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CD80—type 1 diabetes mellitus	4.16e-05	0.000133	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—EGFR—type 1 diabetes mellitus	4.16e-05	0.000133	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IGF2—type 1 diabetes mellitus	4.15e-05	0.000132	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL11—type 1 diabetes mellitus	4.13e-05	0.000132	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL20—type 1 diabetes mellitus	4.13e-05	0.000132	CbGpPWpGaD
Celecoxib—MAPK14—Cellular Senescence—IL6—type 1 diabetes mellitus	4.11e-05	0.000131	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IGF1—type 1 diabetes mellitus	4.1e-05	0.000131	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IGF1—type 1 diabetes mellitus	4.09e-05	0.00013	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CTLA4—type 1 diabetes mellitus	4.05e-05	0.000129	CbGpPWpGaD
Celecoxib—CA12—Metabolism—ALB—type 1 diabetes mellitus	4.04e-05	0.000129	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CD80—type 1 diabetes mellitus	4.02e-05	0.000128	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CD86—type 1 diabetes mellitus	4e-05	0.000127	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—EGFR—type 1 diabetes mellitus	4e-05	0.000127	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS1—type 1 diabetes mellitus	3.99e-05	0.000127	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ABCC8—type 1 diabetes mellitus	3.99e-05	0.000127	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HBA2—type 1 diabetes mellitus	3.96e-05	0.000126	CbGpPWpGaD
Celecoxib—PDPK1—Disease—INS—type 1 diabetes mellitus	3.94e-05	0.000125	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CHRM2—type 1 diabetes mellitus	3.88e-05	0.000124	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—ALB—type 1 diabetes mellitus	3.87e-05	0.000123	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	3.87e-05	0.000123	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD79A—type 1 diabetes mellitus	3.87e-05	0.000123	CbGpPWpGaD
Celecoxib—CA12—Metabolism—NOS3—type 1 diabetes mellitus	3.86e-05	0.000123	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TYK2—type 1 diabetes mellitus	3.85e-05	0.000123	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	3.83e-05	0.000122	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	3.82e-05	0.000122	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—TYK2—type 1 diabetes mellitus	3.81e-05	0.000121	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PRKCQ—type 1 diabetes mellitus	3.79e-05	0.000121	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.79e-05	0.000121	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—EGFR—type 1 diabetes mellitus	3.79e-05	0.000121	CbGpPWpGaD
Celecoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	3.79e-05	0.000121	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL6—type 1 diabetes mellitus	3.78e-05	0.000121	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PRKCQ—type 1 diabetes mellitus	3.74e-05	0.000119	CbGpPWpGaD
Celecoxib—ALB—Metabolism—G6PC2—type 1 diabetes mellitus	3.72e-05	0.000119	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—NOS3—type 1 diabetes mellitus	3.7e-05	0.000118	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	3.7e-05	0.000118	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—VAV1—type 1 diabetes mellitus	3.69e-05	0.000118	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VAV1—type 1 diabetes mellitus	3.63e-05	0.000116	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.61e-05	0.000115	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—IL2—type 1 diabetes mellitus	3.59e-05	0.000114	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DQA1—type 1 diabetes mellitus	3.57e-05	0.000114	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IFNG—type 1 diabetes mellitus	3.57e-05	0.000114	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.55e-05	0.000113	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TYK2—type 1 diabetes mellitus	3.52e-05	0.000112	CbGpPWpGaD
Celecoxib—CA4—Metabolism—INS—type 1 diabetes mellitus	3.51e-05	0.000112	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.49e-05	0.000111	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ITPR3—type 1 diabetes mellitus	3.48e-05	0.000111	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.47e-05	0.000111	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NOS3—type 1 diabetes mellitus	3.45e-05	0.00011	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD4—type 1 diabetes mellitus	3.44e-05	0.00011	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—TYK2—type 1 diabetes mellitus	3.4e-05	0.000108	CbGpPWpGaD
Celecoxib—CA2—Metabolism—INS—type 1 diabetes mellitus	3.37e-05	0.000107	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	3.35e-05	0.000107	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DQB1—type 1 diabetes mellitus	3.34e-05	0.000106	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SLC11A1—type 1 diabetes mellitus	3.33e-05	0.000106	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IGF2—type 1 diabetes mellitus	3.29e-05	0.000105	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SH2B3—type 1 diabetes mellitus	3.28e-05	0.000105	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	3.27e-05	0.000104	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IAPP—type 1 diabetes mellitus	3.26e-05	0.000104	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APOC3—type 1 diabetes mellitus	3.26e-05	0.000104	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	3.24e-05	0.000103	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ABCC8—type 1 diabetes mellitus	3.23e-05	0.000103	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—VDR—type 1 diabetes mellitus	3.22e-05	0.000103	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ALB—type 1 diabetes mellitus	3.22e-05	0.000103	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD86—type 1 diabetes mellitus	3.21e-05	0.000102	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—IL6—type 1 diabetes mellitus	3.2e-05	0.000102	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	3.19e-05	0.000102	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL1B—type 1 diabetes mellitus	3.18e-05	0.000101	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CD4—type 1 diabetes mellitus	3.18e-05	0.000101	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ITPR3—type 1 diabetes mellitus	3.18e-05	0.000101	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL2—type 1 diabetes mellitus	3.17e-05	0.000101	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—KCNJ11—type 1 diabetes mellitus	3.15e-05	0.000101	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD40LG—type 1 diabetes mellitus	3.15e-05	0.0001	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	3.15e-05	0.0001	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IL2—type 1 diabetes mellitus	3.14e-05	0.0001	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD8A—type 1 diabetes mellitus	3.12e-05	9.94e-05	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—IL6—type 1 diabetes mellitus	3.11e-05	9.9e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ALB—type 1 diabetes mellitus	3.09e-05	9.85e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—NOS3—type 1 diabetes mellitus	3.08e-05	9.82e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CD4—type 1 diabetes mellitus	3.07e-05	9.8e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	3.07e-05	9.8e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	3.05e-05	9.71e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-B—type 1 diabetes mellitus	3e-05	9.56e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IAPP—type 1 diabetes mellitus	2.97e-05	9.47e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOC3—type 1 diabetes mellitus	2.97e-05	9.47e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—NOS3—type 1 diabetes mellitus	2.95e-05	9.42e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CD80—type 1 diabetes mellitus	2.92e-05	9.3e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—IL6—type 1 diabetes mellitus	2.91e-05	9.29e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ERBB3—type 1 diabetes mellitus	2.9e-05	9.24e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SST—type 1 diabetes mellitus	2.86e-05	9.12e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—B2M—type 1 diabetes mellitus	2.85e-05	9.09e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.85e-05	9.08e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—INS—type 1 diabetes mellitus	2.84e-05	9.05e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL2RA—type 1 diabetes mellitus	2.81e-05	8.96e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-A—type 1 diabetes mellitus	2.78e-05	8.86e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL2RA—type 1 diabetes mellitus	2.77e-05	8.83e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—INS—type 1 diabetes mellitus	2.76e-05	8.79e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—STAT3—type 1 diabetes mellitus	2.69e-05	8.59e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—STAT3—type 1 diabetes mellitus	2.67e-05	8.5e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.67e-05	8.5e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	2.66e-05	8.49e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ITPR3—type 1 diabetes mellitus	2.66e-05	8.48e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.65e-05	8.46e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CRP—type 1 diabetes mellitus	2.65e-05	8.45e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	2.64e-05	8.42e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ALB—type 1 diabetes mellitus	2.6e-05	8.3e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—KCNJ11—type 1 diabetes mellitus	2.55e-05	8.13e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GCG—type 1 diabetes mellitus	2.55e-05	8.13e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DRB1—type 1 diabetes mellitus	2.54e-05	8.09e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—HBA1—type 1 diabetes mellitus	2.5e-05	7.98e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—NOS3—type 1 diabetes mellitus	2.49e-05	7.94e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOC3—type 1 diabetes mellitus	2.49e-05	7.93e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.46e-05	7.85e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—STAT3—type 1 diabetes mellitus	2.46e-05	7.85e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.45e-05	7.82e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—EGFR—type 1 diabetes mellitus	2.45e-05	7.81e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTT1—type 1 diabetes mellitus	2.44e-05	7.79e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—EGFR—type 1 diabetes mellitus	2.42e-05	7.73e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.42e-05	7.71e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS1—type 1 diabetes mellitus	2.39e-05	7.62e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.38e-05	7.6e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS2—type 1 diabetes mellitus	2.38e-05	7.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.38e-05	7.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD80—type 1 diabetes mellitus	2.34e-05	7.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—type 1 diabetes mellitus	2.33e-05	7.44e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	2.25e-05	7.18e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PRKCQ—type 1 diabetes mellitus	2.24e-05	7.14e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—EGFR—type 1 diabetes mellitus	2.24e-05	7.13e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—VAV1—type 1 diabetes mellitus	2.17e-05	6.93e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—EGFR—type 1 diabetes mellitus	2.16e-05	6.89e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.16e-05	6.88e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ITPR3—type 1 diabetes mellitus	2.15e-05	6.86e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	2.14e-05	6.81e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IGF1—type 1 diabetes mellitus	2.11e-05	6.73e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	2.11e-05	6.71e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	2.09e-05	6.66e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CD86—type 1 diabetes mellitus	2.08e-05	6.62e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.05e-05	6.54e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL2—type 1 diabetes mellitus	2.05e-05	6.53e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.04e-05	6.5e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HBA1—type 1 diabetes mellitus	2.03e-05	6.46e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOC3—type 1 diabetes mellitus	2.01e-05	6.42e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	2.01e-05	6.4e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—TYK2—type 1 diabetes mellitus	1.98e-05	6.31e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTT1—type 1 diabetes mellitus	1.98e-05	6.3e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.97e-05	6.29e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GCG—type 1 diabetes mellitus	1.95e-05	6.21e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS3—type 1 diabetes mellitus	1.91e-05	6.11e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD86—type 1 diabetes mellitus	1.9e-05	6.04e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—type 1 diabetes mellitus	1.88e-05	6e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.87e-05	5.97e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—type 1 diabetes mellitus	1.86e-05	5.94e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNG—type 1 diabetes mellitus	1.85e-05	5.91e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.84e-05	5.88e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.82e-05	5.79e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD4—type 1 diabetes mellitus	1.79e-05	5.71e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	1.78e-05	5.67e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	1.76e-05	5.62e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	1.74e-05	5.55e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.72e-05	5.5e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—type 1 diabetes mellitus	1.72e-05	5.48e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—ERBB3—type 1 diabetes mellitus	1.71e-05	5.45e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CCR5—type 1 diabetes mellitus	1.68e-05	5.36e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	1.67e-05	5.33e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	1.66e-05	5.3e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—type 1 diabetes mellitus	1.66e-05	5.3e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	1.66e-05	5.29e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1B—type 1 diabetes mellitus	1.65e-05	5.27e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CAT—type 1 diabetes mellitus	1.65e-05	5.26e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	1.65e-05	5.25e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL2—type 1 diabetes mellitus	1.65e-05	5.25e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HLA-A—type 1 diabetes mellitus	1.64e-05	5.22e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	1.63e-05	5.21e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL2—type 1 diabetes mellitus	1.62e-05	5.18e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	1.62e-05	5.16e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GCG—type 1 diabetes mellitus	1.58e-05	5.02e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.57e-05	5e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CD80—type 1 diabetes mellitus	1.52e-05	4.83e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.49e-05	4.76e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—INS—type 1 diabetes mellitus	1.43e-05	4.57e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS2—type 1 diabetes mellitus	1.43e-05	4.54e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—STAT3—type 1 diabetes mellitus	1.39e-05	4.42e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.39e-05	4.42e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD80—type 1 diabetes mellitus	1.38e-05	4.41e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	1.38e-05	4.39e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CAT—type 1 diabetes mellitus	1.33e-05	4.25e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—INS—type 1 diabetes mellitus	1.31e-05	4.17e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	1.3e-05	4.15e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	1.29e-05	4.11e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.28e-05	4.08e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EGFR—type 1 diabetes mellitus	1.26e-05	4.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.26e-05	4e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.2e-05	3.84e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TYK2—type 1 diabetes mellitus	1.17e-05	3.72e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	1.16e-05	3.7e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS3—type 1 diabetes mellitus	1.15e-05	3.65e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	1.1e-05	3.51e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—INS—type 1 diabetes mellitus	1.09e-05	3.49e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	1.09e-05	3.49e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	1.09e-05	3.48e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	1.09e-05	3.47e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	1.07e-05	3.4e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.07e-05	3.4e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2—type 1 diabetes mellitus	1.06e-05	3.39e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD4—type 1 diabetes mellitus	1.06e-05	3.37e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALB—type 1 diabetes mellitus	1e-05	3.2e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—type 1 diabetes mellitus	9.68e-06	3.09e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NOS3—type 1 diabetes mellitus	9.6e-06	3.06e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.96e-06	2.86e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—INS—type 1 diabetes mellitus	8.85e-06	2.82e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	8.5e-06	2.71e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—STAT3—type 1 diabetes mellitus	8.17e-06	2.61e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EGFR—type 1 diabetes mellitus	8.14e-06	2.6e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NOS3—type 1 diabetes mellitus	7.76e-06	2.48e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EGFR—type 1 diabetes mellitus	7.43e-06	2.37e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	7.31e-06	2.33e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	7.25e-06	2.31e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	7.2e-06	2.3e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	6.7e-06	2.14e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	6.64e-06	2.12e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	6.41e-06	2.04e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	6.35e-06	2.03e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—type 1 diabetes mellitus	6.26e-06	2e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—type 1 diabetes mellitus	5.71e-06	1.82e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	4.78e-06	1.52e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	4.38e-06	1.4e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	4.19e-06	1.34e-05	CbGpPWpGaD
